An observational study in Rehabilitation, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2024-11-06.
Sponsored by Assiut University · Observational
This study aims to explore the effects of exercise rehabilitation on the functional status of patients with pulmonary fibrosis, assessing both physical and psychological dimensions of health. By identifying significant improvements, we can contribute to the development of comprehensive rehabilitation strategies that enhance patient outcomes and foster a better quality of life for those affected by this challenging condition
program is essential for understanding its efficacy. Functional status refers to an individual's ability to perform daily activities and maintain independence, which is particularly important for patients with chronic illnesses like PF. Evaluating changes in functional status not only helps in determining the success of rehabilitation efforts but also provides insights into the overall impact of exercise on patients' quality of life.
Assiut University is the lead sponsor of 5,050 studies on the registry; 2,174 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
**Demographic Data Collection:**
Age, sex, duration of pulmonary fibrosis, and medical history.
2. **Pulmonary Function Testing:**
Spirometry will be conducted to assess Forced Vital Capacity (FVC) and Forced Expiratory Volume in one second (FEV1).
3. **Functional Capacity Assessment:**
The Six-Minute Walk Test (6MWT) will be performed to evaluate baseline exercise tolerance.
4. **Quality of Life Evaluation:**
Health-related quality of life will be assessed using the St. George's Respiratory Questionnaire (SGRQ) or Chronic Respiratory Disease Questionnaire (CRQ).
5. **Dyspnea Assessment:**
Dyspnea levels will be measured using the Modified Medical Research Council (mMRC) dyspnea scale.
Participants will engage in a structured 8-week exercise rehabilitation program, which includes:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients must have a confirmed diagnosis of pulmonary fibrosis, as determined by clinical evaluation and imaging studies (e.g., high-resolution computed tomography).
2. **Age Range:**
Participants should be adults aged 18 years and older to capture the adult population affected by the disease.
3. **Stable Clinical Condition:**
Exclusion Criteria:
Patients with concurrent respiratory conditions (e.g., chronic obstructive pulmonary disease, asthma, or lung cancer) that could confound the results.
2. **Acute Exacerbations:**
Individuals experiencing an acute exacerbation of pulmonary fibrosis or any significant respiratory illness within four weeks prior to enrollment.
3. **Severe Comorbidities:**
Patients with severe cardiovascular disease, uncontrolled hypertension, major neurological disorders, or musculoskeletal problems that would impede participation in exercise.
4. **Cognitive Impairment:**
**Asses Health-Related Quality of Life:**
Assessed through validated questionnaires such as the St. George's Respiratory Questionnaire (SGRQ)
Time frame: Baseline
No study locations are listed for this record.
Plan to share: No
This study is not yet recruiting, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.